Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1992;70(6):745–750.

Diagnosis of measles by clinical case definition in dengue-endemic areas: implications for measles surveillance and control.

V J Dietz 1, P Nieburg 1, D J Gubler 1, I Gomez 1
PMCID: PMC2393413  PMID: 1486671

Abstract

In many countries, measles surveillance relies heavily on the use of a standard clinical case definition; however, the clinical signs and symptoms of measles are similar to those of dengue. For example, during 1985, in Puerto Rico, 22 (23%) of 94 cases of illnesses with rashes that met the measles clinical case definition were serologically confirmed as measles, but 32 (34%) others were serologically confirmed as dengue. Retrospective analysis at the San Juan Laboratories of the Centers for Disease Control showed also that at least 28% of all laboratory-confirmed cases of dengue in Puerto Rico in 1985 met the measles clinical case definition. If the true measles vaccine efficacy (VE) is assumed to be 90%, the occurrence of laboratory-confirmed dengue cases that meet the measles clinical case definition results in a reduction of the apparent measles VE to only 64% (a 29% relative reduction from the true VE). The results of the study demonstrate the importance of a laboratory-based surveillance system in measles control or elimination efforts in dengue-endemic areas.

Full text

PDF
745

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CLARKE D. H., CASALS J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg. 1958 Sep;7(5):561–573. doi: 10.4269/ajtmh.1958.7.561. [DOI] [PubMed] [Google Scholar]
  2. Centers for Disease Control (CDC) Classification of measles cases and categorization of measles elimination programs. MMWR Morb Mortal Wkly Rep. 1983 Jan 7;31(52):707–711. [PubMed] [Google Scholar]
  3. Gubler D. J., Kuno G., Sather G. E., Velez M., Oliver A. Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. Am J Trop Med Hyg. 1984 Jan;33(1):158–165. doi: 10.4269/ajtmh.1984.33.158. [DOI] [PubMed] [Google Scholar]
  4. Henderson R. H., Keja J., Hayden G., Galazka A., Clements J., Chan C. Immunizing the children of the world: progress and prospects. Bull World Health Organ. 1988;66(5):535–543. [PMC free article] [PubMed] [Google Scholar]
  5. Morens D. M., Rigau-Pérez J. G., López-Correa R. H., Moore C. G., Ruiz-Tibén E. E., Sather G. E., Chiriboga J., Eliason D. A., Casta-Velez A., Woodall J. P. Dengue in Puerto Rico, 1977: public health response to characterize and control an epidemic of multiple serotypes. Am J Trop Med Hyg. 1986 Jan;35(1):197–211. doi: 10.4269/ajtmh.1986.35.197. [DOI] [PubMed] [Google Scholar]
  6. Orenstein W. A., Bernier R. H., Dondero T. J., Hinman A. R., Marks J. S., Bart K. J., Sirotkin B. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63(6):1055–1068. [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES